Mucuna Beans Show Promise for Advanced Parkinson's Disease Treatment
- Authors
- Ryuji Neshige, Shuichiro Neshige
- Journal
- Clinical Parkinsonism & Related Disorders
- Year
- 2024
- DOI
- 10.1016/j.prdoa.2024.100252
- Study Type
- Human
- Outcome
- Neutral
- Peer Reviewed
- Yes
- Country
- Japan
- Health Condition
- Parkinson's Disease
- Body System
- Nervous System
TL;DR
A study reviewed how Parkinson's disease patients responded to treatments with mucuna beans, taken either by mouth or as an enema.
Key Finding
Mucuna beans containing L-dopa can be administered orally at 1-3 grams daily or potentially via enema as an alternative route in Parkinson's disease patients.
Summary
This review looked back at medical records of 200 Parkinson's disease patients who took mucuna beans (a plant that naturally contains L-dopa, a medication used to treat Parkinson's) in doses of 1-3 grams daily mixed in hot water. The researchers also noted that mucuna beans could potentially be given as an enema (liquid inserted into the colon) when taking them by mouth became less effective. The study suggests this natural source of L-dopa may help manage Parkinson's symptoms through different delivery methods.
Practical Takeaway
While this retrospective review of 200 patients suggests mucuna beans may offer a natural alternative to synthetic L-dopa medications, the lack of reported results and absence of a control group limit what we can conclude. Larger, controlled studies would be needed to confirm whether mucuna beans are truly effective and to determine optimal dosing and administration methods for Parkinson's disease.
Abstract
This retrospective review on patients with Parkinson's disease, focusing on using mucuna beans (MB), its dosing, and administration methods. Two hundred patients taking 1-3 g of MP dissolved in hot water daily orally. Besides, MB administration via enema may be viable, especially when oral L-dopa efficacy is insufficient.